China’s "artificial sun" EAST fusion reactor smashed the previous record for sustained plasma, advancing nuclear fusion ...
There has been another twist in the road for the ongoing legal battle between Seagen and Daiichi Sankyo over patent rights for antibody-drug conjugate (ADC) Enhertu. The US Patent and Trademark ...
MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback